• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    161.36 Up 4.03(2.56%) Mar 5, 4:00PM EST
    |After Hours : 161.36 0.00 (0.00%) Mar 5, 4:26PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 346,363   329,951   322,802   289,403  
    Cost of Revenue15,770  40,804  38,709  30,600  
    Gross Profit 330,593   289,147   284,093   258,803  
    Operating Expenses
    Research Development71,482  118,877  39,742  12,448  
    Selling General and Administrative80,534  202,507  68,031  30,215  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 178,577   (32,237) 176,320   216,140  
    Income from Continuing Operations
    Total Other Income/Expenses Net(286)1,113  1,459  1,686  
    Earnings Before Interest And Taxes178,291  (31,124)177,779  217,826  
    Interest Expense3,527  4,709  4,746  4,610  
    Income Before Tax174,764  (35,833)173,033  213,216  
    Income Tax Expense58,829  (10,596)61,181  75,692  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops115,935  (25,237)111,852  137,524  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 115,935   (25,237) 111,852   137,524  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 115,935   (25,237) 111,852   137,524  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.